PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Rhea-AI Summary

PacBio (NASDAQ: PACB), a top developer of high-quality sequencing solutions, announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The company's management will engage in a fireside chat on Thursday, September 5, at 1:05 p.m. Eastern Time.

The event will be live-streamed on PacBio's investors page at investor.pacificbiosciences.com. For those unable to attend live, a replay will be available for at least 30 days following the event. This presentation offers investors and interested parties an opportunity to gain insights into PacBio's latest developments and future prospects in the sequencing technology sector.

News Market Reaction – PACB

-8.13%

-8.13% Session move

In the trading session that priced this news, PACB declined 8.13%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MENLO PARK, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, at 1:05 p.m. Eastern Time.

The event will be live-streamed on the company's investors page at investor.pacificbiosciences.com. A replay will be available for at least 30 days following the event.

About PacBio

PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our HiFi long-read sequencing and our SBB® short-read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.

PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.

Contacts

Investors:
Todd Friedman
ir@pacb.com

Media:
pr@pacb.com

FAQ

When is PacBio (PACB) presenting at the Morgan Stanley Global Healthcare Conference?

PacBio (PACB) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, at 1:05 p.m. Eastern Time.

How can I watch PacBio's (PACB) presentation at the Morgan Stanley conference?

You can watch PacBio's (PACB) presentation via live-stream on the company's investors page at investor.pacificbiosciences.com.

Will there be a replay available of PacBio's (PACB) Morgan Stanley conference presentation?

Yes, a replay of PacBio's (PACB) presentation will be available for at least 30 days following the event on their investors page.

What type of presentation will PacBio (PACB) give at the Morgan Stanley Healthcare Conference?

PacBio (PACB) management will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference.